Need professional-grade analysis? Visit stockanalysis.com
$82.10B
24.81
1,097
3.49%
Sanofi India Limited (SANOFI) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at INR3559.80, down 0.03% from the previous close.
Over the past year, SANOFI has traded between a low of INR3190.90 and a high of INR5187.71. The stock has lost 30.2% over this period. It is currently 31.4% below its 52-week high.
Sanofi India Limited has a market capitalization of $82.10B, with a price-to-earnings ratio of 24.81 and a dividend yield of 3.49%.
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Side-by-side comparison against top Healthcare peers.